Navigation Links
ISTA Pharmaceuticals Announces 2010 Financial Guidance
Date:2/9/2010

/span> and anticipate sales from Bepreve will be at least $20 million.  As in previous years, our net sales are seasonal, with first quarter net sales typically being the lowest of the year and less than the prior quarter.
  • We expect our gross margin in 2010 will be in the range of 74% to 76%.
  • We expect R&D expenses to be approximately 18% to 22% of net revenue, depending upon the progress of our clinical programs.  In 2010, we will focus our development activities on our bromfenac formulation as a treatment for dry eye disease and our nasal bepotastine formulation for nasal allergies.  During 2010, we anticipate initiating our full-scale Phase 3 clinical program in dry eye disease, as well as the long-term safety study required by the FDA in advance of a New Drug Application (NDA) filing.  To maximize our bepotastine franchise, we will complete our formulation work for bepotastine nasal and anticipate initiating the clinical program with this product as a treatment for nasal allergies in 2010.
  • We expect SG&A expenses for 2010 to be approximately 48% to 52% of net revenue.
  • We expect our operating income for 2010 will be $8 to $10 million.
  • We expect our net income for 2010 will be at least $1 million, or earnings per share of $0.02, excluding any mark-to-market adjustments relating to warrants.  Once we are profitable, we expect our fully diluted common shares, including our outstanding shares of common stock, warrants and stock options on a treasury stock basis, will be approximately 49 million shares.
  • We expect our business to generate $6 to $10 million in cash in 2010.

  • As previously announced on February 1, 2010, the Company will issue full financial results for 2009 after market
    '/>"/>

    SOURCE ISTA Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
    6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
    8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
    9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
    10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
    11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/7/2015)... -- Research and Markets ( ... "The New Trends of Global Preclinical Development ... The report, The New Trends of Global ... the current development states and the future growth ... The report is designed to reveal the latest ...
    (Date:7/7/2015)... 2015  The Arentz Law Group is currently investigating cases ... .  Women who have taken Zyban while pregnant, and given ... encouraged to contact the law firm immediately for a ... in the American Journal of Obstetrics & Gynecology  showed ... risk of giving birth to a child with " left ...
    (Date:7/7/2015)... NEWTOWN, Pennsylvania , 7. Juli 2015 /PRNewswire/ ... Spezial-Dienstleistungen und -Technik für klinische Studien, gab heute ... (Medici) ein führendes Unternehmen bei Gewinnung und Erhalt ... umfasst die Tochtergesellschaften MediciGlobal , Ltd. und ... L2FU® auch einen Dienst zum Auffinden von ...
    Breaking Medicine Technology:New Trends in the 2015 Global Preclinical Development Outsourcing Market 2New Trends in the 2015 Global Preclinical Development Outsourcing Market 3New Trends in the 2015 Global Preclinical Development Outsourcing Market 4New Trends in the 2015 Global Preclinical Development Outsourcing Market 5Smoking cessation drug linked to birth defects when taken during pregnancy 2BioClinica übernimmt MediciGroup 2BioClinica übernimmt MediciGroup 3BioClinica übernimmt MediciGroup 4
    ... is the number one cause of all recent agents ... to 74 years of age, according to Transitions Optical,s ... diagnosed by a primary healthcare provider like an internist, ... the ocular signs of the disease. ...
    ... Nov. 17, 2010 Reportlinker.com announces that a new ... European Markets for Wound and Tissue Management ... In 2009, the total European wound and tissue management ... European markets for wound and tissue management covers 15 ...
    Cached Medicine Technology:The Truth About Diabetes and Visual Complications Unveiled 2The Truth About Diabetes and Visual Complications Unveiled 3Reportlinker Adds European Markets for Wound and Tissue Management 2011 2Reportlinker Adds European Markets for Wound and Tissue Management 2011 3Reportlinker Adds European Markets for Wound and Tissue Management 2011 4Reportlinker Adds European Markets for Wound and Tissue Management 2011 5Reportlinker Adds European Markets for Wound and Tissue Management 2011 6Reportlinker Adds European Markets for Wound and Tissue Management 2011 7Reportlinker Adds European Markets for Wound and Tissue Management 2011 8Reportlinker Adds European Markets for Wound and Tissue Management 2011 9Reportlinker Adds European Markets for Wound and Tissue Management 2011 10Reportlinker Adds European Markets for Wound and Tissue Management 2011 11Reportlinker Adds European Markets for Wound and Tissue Management 2011 12Reportlinker Adds European Markets for Wound and Tissue Management 2011 13Reportlinker Adds European Markets for Wound and Tissue Management 2011 14Reportlinker Adds European Markets for Wound and Tissue Management 2011 15Reportlinker Adds European Markets for Wound and Tissue Management 2011 16Reportlinker Adds European Markets for Wound and Tissue Management 2011 17Reportlinker Adds European Markets for Wound and Tissue Management 2011 18Reportlinker Adds European Markets for Wound and Tissue Management 2011 19Reportlinker Adds European Markets for Wound and Tissue Management 2011 20Reportlinker Adds European Markets for Wound and Tissue Management 2011 21Reportlinker Adds European Markets for Wound and Tissue Management 2011 22Reportlinker Adds European Markets for Wound and Tissue Management 2011 23
    (Date:7/7/2015)... ... July 07, 2015 , ... Dr. Poneh Ghasri , cosmetic dentist ... professional teeth whitening is one of the fastest, easiest ways to brighten a smile. ... decrease smile satisfaction and confidence. With the right teeth whitening treatment, patients can restore ...
    (Date:7/7/2015)... ... July 07, 2015 , ... America is blessed with people who continually ... Hero program offers a special way to say “thanks.” Give them the recognition ... gift card and their place on the “Wall of Heroes.” , “We hear ...
    (Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... executive Ellen Purdy as the company’s new Chief Financial Officer, effective July 6th, ... leadership experience in companies ranging from a multi-billion dollar, global chemical company to ...
    (Date:7/7/2015)... ... July 07, 2015 , ... ... with strong managerial expertise to oversee large healthcare operations and their success ... business partners, insurance companies, and regulators. American Sentinel University, an innovative, accredited ...
    (Date:7/7/2015)... ... July 07, 2015 , ... ... provider of unified communication management solutions, has announced the release of Service ... This service pack includes a number of enhancements to the already robust ...
    Breaking Medicine News(10 mins):Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 2Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 3Health News:California Casualty Wants to Know: "Who Is Your Hero?" 2Health News:Office Practicum Announces new CFO 2Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 2Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 3Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 4Health News:ISI Telemanagement Solutions, Inc. Releases Service Pack 5600 for Infortel® Select 2
    ... --, LAKE FOREST, Ill., Feb. 28 Hospira, Inc.,(NYSE: ... reported results for the fourth quarter and full,year ended Dec. 31, ... percent to $946.1 million in the fourth ... last year. Net sales excluding Mayne Pharma ...
    ... Run Ads in Heavy Rotation Through Primary, ... of Ohio,s crucial,primary vote Tuesday, the National Nurses ... campaign across Ohio with,an emphatic message to the ... support real healthcare reform., The 60-second radio ...
    ... effective treatment for lowering cholesterol, are widely used ... large clinical trials. Although side effects are usually ... have been reported. Tendon impairment has been reported ... studies. A new study published in the March ...
    ... Thomson Research Award Ceremony Celebrates the Best in Australian ... Held at the National Press Club on 2 April, ... of The Thomson Corporation (NYSE: TOC ; TSX: ... research and business,communities, today announced it will honor Australia,s ...
    ... Actavis Group, the,international generic pharmaceuticals company, has ... Food & Drug Administration., The four products ... equivalent of,Bontril(R) tablets by Valeant Pharmaceuticals, are indicated ... of Phendimetrazine tartrate tablets,had annual sales of US$3.1 ...
    ... Pictures Television,International,s (SPTI) Latin American advertising sales group ... detection campaign in,support of Latin American women. The ... and SPTI,s powerful media,reach to assist Latin America ... is called "SER," which means "to be" in ...
    Cached Medicine News:Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 2Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 3Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 4Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 5Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 6Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 7Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 8Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 9Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 10Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 11Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 12Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 13Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 14Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 15Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 16Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 17Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 18Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 19Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 20Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 21Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 22Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 23Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 24Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 25Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 26Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 27Health News:Hospira Reports Fourth-Quarter and Full-Year 2007 Results 28Health News:Nurses Launch Major Ohio Radio Ad Campaign Telling Candidates: Stop Selling Insurance and Back Real Reform 2Health News:Nurses Launch Major Ohio Radio Ad Campaign Telling Candidates: Stop Selling Insurance and Back Real Reform 3Health News:Tendon complications, though rare, linked to statins 2Health News:Thomson Scientific To Honor Australia's Top Researchers With Dedicated Australian Research Day 2Health News:Thomson Scientific To Honor Australia's Top Researchers With Dedicated Australian Research Day 3Health News:Actavis Extends Portfolio With Four New Products in the U.S. 2Health News:Novartis and Sony Pictures Television International's Latin American Advertising Sales Group Launch Partnership to Create Multi-Media Platform for Breast Cancer Awareness, Detection, and Treatment in Latin America 2Health News:Novartis and Sony Pictures Television International's Latin American Advertising Sales Group Launch Partnership to Create Multi-Media Platform for Breast Cancer Awareness, Detection, and Treatment in Latin America 3
    Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
    Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
    ... provide a broad selection of ... a wide variety of ophthalmic ... is packaged sterile, complete with ... switch in the "off " ...
    ... provide a broad selection of ... a wide variety of ophthalmic ... is packaged sterile, complete with ... switch in the "off " ...
    Medicine Products: